nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—CYP3A4—bone cancer	0.791	1	CbGaD
Trazodone—Vilazodone—CYP3A4—bone cancer	0.00211	0.315	CrCbGaD
Trazodone—Domperidone—CYP3A4—bone cancer	0.00081	0.121	CrCbGaD
Trazodone—Ziprasidone—CYP3A4—bone cancer	0.0008	0.119	CrCbGaD
Trazodone—Nefazodone—CYP3A4—bone cancer	0.000673	0.1	CrCbGaD
Trazodone—Bladder pain—Epirubicin—bone cancer	0.000671	0.00412	CcSEcCtD
Trazodone—Salivary hypersecretion—Doxorubicin—bone cancer	0.000666	0.0041	CcSEcCtD
Trazodone—Polyuria—Methotrexate—bone cancer	0.000655	0.00403	CcSEcCtD
Trazodone—Photosensitivity—Methotrexate—bone cancer	0.000655	0.00403	CcSEcCtD
Trazodone—Arrhythmia—Cisplatin—bone cancer	0.000648	0.00398	CcSEcCtD
Trazodone—Mental disability—Epirubicin—bone cancer	0.000644	0.00396	CcSEcCtD
Trazodone—Alopecia—Cisplatin—bone cancer	0.000641	0.00394	CcSEcCtD
Trazodone—Dry eye—Doxorubicin—bone cancer	0.000634	0.0039	CcSEcCtD
Trazodone—Aripiprazole—CYP3A4—bone cancer	0.000625	0.0933	CrCbGaD
Trazodone—Flatulence—Cisplatin—bone cancer	0.000622	0.00382	CcSEcCtD
Trazodone—Bladder pain—Doxorubicin—bone cancer	0.00062	0.00381	CcSEcCtD
Trazodone—Photosensitivity—Epirubicin—bone cancer	0.000613	0.00377	CcSEcCtD
Trazodone—Visual disturbance—Methotrexate—bone cancer	0.000607	0.00373	CcSEcCtD
Trazodone—Eye pain—Epirubicin—bone cancer	0.000596	0.00367	CcSEcCtD
Trazodone—Mental disability—Doxorubicin—bone cancer	0.000595	0.00366	CcSEcCtD
Trazodone—Vision blurred—Cisplatin—bone cancer	0.000595	0.00366	CcSEcCtD
Trazodone—Cardiac failure congestive—Epirubicin—bone cancer	0.000594	0.00365	CcSEcCtD
Trazodone—Tremor—Cisplatin—bone cancer	0.000591	0.00364	CcSEcCtD
Trazodone—Lethargy—Methotrexate—bone cancer	0.000587	0.00361	CcSEcCtD
Trazodone—Cerebrovascular accident—Methotrexate—bone cancer	0.000587	0.00361	CcSEcCtD
Trazodone—Ill-defined disorder—Cisplatin—bone cancer	0.000586	0.0036	CcSEcCtD
Trazodone—Anaemia—Cisplatin—bone cancer	0.000583	0.00359	CcSEcCtD
Trazodone—Increased appetite—Epirubicin—bone cancer	0.000573	0.00352	CcSEcCtD
Trazodone—Malaise—Cisplatin—bone cancer	0.000569	0.0035	CcSEcCtD
Trazodone—Photosensitivity—Doxorubicin—bone cancer	0.000567	0.00349	CcSEcCtD
Trazodone—Prochlorperazine—CYP3A4—bone cancer	0.000557	0.0831	CrCbGaD
Trazodone—Eye pain—Doxorubicin—bone cancer	0.000552	0.00339	CcSEcCtD
Trazodone—Lethargy—Epirubicin—bone cancer	0.000549	0.00338	CcSEcCtD
Trazodone—Cerebrovascular accident—Epirubicin—bone cancer	0.000549	0.00338	CcSEcCtD
Trazodone—Cardiac failure congestive—Doxorubicin—bone cancer	0.000549	0.00338	CcSEcCtD
Trazodone—Ataxia—Methotrexate—bone cancer	0.000541	0.00333	CcSEcCtD
Trazodone—Hyponatraemia—Epirubicin—bone cancer	0.00054	0.00332	CcSEcCtD
Trazodone—Diplopia—Epirubicin—bone cancer	0.000538	0.00331	CcSEcCtD
Trazodone—Myalgia—Cisplatin—bone cancer	0.000537	0.0033	CcSEcCtD
Trazodone—Anxiety—Cisplatin—bone cancer	0.000536	0.00329	CcSEcCtD
Trazodone—Discomfort—Cisplatin—bone cancer	0.000531	0.00326	CcSEcCtD
Trazodone—Increased appetite—Doxorubicin—bone cancer	0.00053	0.00326	CcSEcCtD
Trazodone—Migraine—Epirubicin—bone cancer	0.00053	0.00326	CcSEcCtD
Trazodone—Oedema—Cisplatin—bone cancer	0.000515	0.00317	CcSEcCtD
Trazodone—Cardiac arrest—Epirubicin—bone cancer	0.000512	0.00315	CcSEcCtD
Trazodone—Cerebrovascular accident—Doxorubicin—bone cancer	0.000508	0.00312	CcSEcCtD
Trazodone—Lethargy—Doxorubicin—bone cancer	0.000508	0.00312	CcSEcCtD
Trazodone—Ataxia—Epirubicin—bone cancer	0.000506	0.00311	CcSEcCtD
Trazodone—Tachycardia—Cisplatin—bone cancer	0.000503	0.00309	CcSEcCtD
Trazodone—Hyponatraemia—Doxorubicin—bone cancer	0.0005	0.00307	CcSEcCtD
Trazodone—Diplopia—Doxorubicin—bone cancer	0.000498	0.00306	CcSEcCtD
Trazodone—Hyperhidrosis—Cisplatin—bone cancer	0.000498	0.00306	CcSEcCtD
Trazodone—Orthostatic hypotension—Epirubicin—bone cancer	0.000492	0.00302	CcSEcCtD
Trazodone—Anorexia—Cisplatin—bone cancer	0.000491	0.00302	CcSEcCtD
Trazodone—Migraine—Doxorubicin—bone cancer	0.00049	0.00301	CcSEcCtD
Trazodone—Hypotension—Cisplatin—bone cancer	0.000481	0.00296	CcSEcCtD
Trazodone—Abdominal discomfort—Methotrexate—bone cancer	0.000477	0.00293	CcSEcCtD
Trazodone—Cardiac arrest—Doxorubicin—bone cancer	0.000474	0.00291	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000469	0.00289	CcSEcCtD
Trazodone—Ataxia—Doxorubicin—bone cancer	0.000468	0.00288	CcSEcCtD
Trazodone—Paraesthesia—Cisplatin—bone cancer	0.000463	0.00284	CcSEcCtD
Trazodone—Dyspnoea—Cisplatin—bone cancer	0.000459	0.00282	CcSEcCtD
Trazodone—Erectile dysfunction—Methotrexate—bone cancer	0.000458	0.00282	CcSEcCtD
Trazodone—Orthostatic hypotension—Doxorubicin—bone cancer	0.000455	0.0028	CcSEcCtD
Trazodone—Photosensitivity reaction—Methotrexate—bone cancer	0.000454	0.00279	CcSEcCtD
Trazodone—Decreased appetite—Cisplatin—bone cancer	0.000448	0.00275	CcSEcCtD
Trazodone—Drowsiness—Methotrexate—bone cancer	0.000443	0.00273	CcSEcCtD
Trazodone—Pain—Cisplatin—bone cancer	0.000441	0.00271	CcSEcCtD
Trazodone—Pollakiuria—Epirubicin—bone cancer	0.00043	0.00264	CcSEcCtD
Trazodone—Sweating—Methotrexate—bone cancer	0.000425	0.00261	CcSEcCtD
Trazodone—Photosensitivity reaction—Epirubicin—bone cancer	0.000425	0.00261	CcSEcCtD
Trazodone—Feeling abnormal—Cisplatin—bone cancer	0.000425	0.00261	CcSEcCtD
Trazodone—Weight increased—Epirubicin—bone cancer	0.000423	0.0026	CcSEcCtD
Trazodone—Haematuria—Methotrexate—bone cancer	0.000423	0.0026	CcSEcCtD
Trazodone—Weight decreased—Epirubicin—bone cancer	0.000421	0.00259	CcSEcCtD
Trazodone—Drowsiness—Epirubicin—bone cancer	0.000415	0.00255	CcSEcCtD
Trazodone—Body temperature increased—Cisplatin—bone cancer	0.000407	0.0025	CcSEcCtD
Trazodone—Jaundice—Epirubicin—bone cancer	0.000404	0.00249	CcSEcCtD
Trazodone—Perphenazine—CYP3A4—bone cancer	0.000399	0.0594	CrCbGaD
Trazodone—Sweating—Epirubicin—bone cancer	0.000398	0.00245	CcSEcCtD
Trazodone—Pollakiuria—Doxorubicin—bone cancer	0.000398	0.00244	CcSEcCtD
Trazodone—Haematuria—Epirubicin—bone cancer	0.000396	0.00243	CcSEcCtD
Trazodone—Photosensitivity reaction—Doxorubicin—bone cancer	0.000393	0.00242	CcSEcCtD
Trazodone—Weight increased—Doxorubicin—bone cancer	0.000392	0.00241	CcSEcCtD
Trazodone—Quetiapine—CYP3A4—bone cancer	0.000391	0.0583	CrCbGaD
Trazodone—Weight decreased—Doxorubicin—bone cancer	0.000389	0.00239	CcSEcCtD
Trazodone—Drowsiness—Doxorubicin—bone cancer	0.000384	0.00236	CcSEcCtD
Trazodone—Visual impairment—Methotrexate—bone cancer	0.000384	0.00236	CcSEcCtD
Trazodone—Hypersensitivity—Cisplatin—bone cancer	0.00038	0.00233	CcSEcCtD
Trazodone—Bradycardia—Epirubicin—bone cancer	0.000379	0.00233	CcSEcCtD
Trazodone—Jaundice—Doxorubicin—bone cancer	0.000374	0.0023	CcSEcCtD
Trazodone—Tinnitus—Methotrexate—bone cancer	0.000371	0.00228	CcSEcCtD
Trazodone—Hypoaesthesia—Epirubicin—bone cancer	0.000371	0.00228	CcSEcCtD
Trazodone—Asthenia—Cisplatin—bone cancer	0.00037	0.00227	CcSEcCtD
Trazodone—Sweating—Doxorubicin—bone cancer	0.000368	0.00226	CcSEcCtD
Trazodone—Haematuria—Doxorubicin—bone cancer	0.000366	0.00225	CcSEcCtD
Trazodone—Visual impairment—Epirubicin—bone cancer	0.000359	0.00221	CcSEcCtD
Trazodone—Chills—Methotrexate—bone cancer	0.000357	0.0022	CcSEcCtD
Trazodone—Diarrhoea—Cisplatin—bone cancer	0.000353	0.00217	CcSEcCtD
Trazodone—Alopecia—Methotrexate—bone cancer	0.000352	0.00216	CcSEcCtD
Trazodone—Bradycardia—Doxorubicin—bone cancer	0.000351	0.00216	CcSEcCtD
Trazodone—Tinnitus—Epirubicin—bone cancer	0.000347	0.00213	CcSEcCtD
Trazodone—Flushing—Epirubicin—bone cancer	0.000346	0.00212	CcSEcCtD
Trazodone—Hypoaesthesia—Doxorubicin—bone cancer	0.000343	0.00211	CcSEcCtD
Trazodone—Dysgeusia—Methotrexate—bone cancer	0.000339	0.00209	CcSEcCtD
Trazodone—Clozapine—CYP3A4—bone cancer	0.000336	0.0501	CrCbGaD
Trazodone—Back pain—Methotrexate—bone cancer	0.000335	0.00206	CcSEcCtD
Trazodone—Chills—Epirubicin—bone cancer	0.000334	0.00205	CcSEcCtD
Trazodone—Arrhythmia—Epirubicin—bone cancer	0.000333	0.00205	CcSEcCtD
Trazodone—Visual impairment—Doxorubicin—bone cancer	0.000332	0.00204	CcSEcCtD
Trazodone—Alopecia—Epirubicin—bone cancer	0.000329	0.00202	CcSEcCtD
Trazodone—Vomiting—Cisplatin—bone cancer	0.000328	0.00201	CcSEcCtD
Trazodone—Vision blurred—Methotrexate—bone cancer	0.000326	0.00201	CcSEcCtD
Trazodone—Rash—Cisplatin—bone cancer	0.000325	0.002	CcSEcCtD
Trazodone—Dermatitis—Cisplatin—bone cancer	0.000325	0.002	CcSEcCtD
Trazodone—Ill-defined disorder—Methotrexate—bone cancer	0.000321	0.00198	CcSEcCtD
Trazodone—Tinnitus—Doxorubicin—bone cancer	0.000321	0.00198	CcSEcCtD
Trazodone—Anaemia—Methotrexate—bone cancer	0.00032	0.00197	CcSEcCtD
Trazodone—Flushing—Doxorubicin—bone cancer	0.00032	0.00197	CcSEcCtD
Trazodone—Flatulence—Epirubicin—bone cancer	0.000319	0.00196	CcSEcCtD
Trazodone—Tension—Epirubicin—bone cancer	0.000318	0.00196	CcSEcCtD
Trazodone—Dysgeusia—Epirubicin—bone cancer	0.000317	0.00195	CcSEcCtD
Trazodone—Nervousness—Epirubicin—bone cancer	0.000315	0.00194	CcSEcCtD
Trazodone—Back pain—Epirubicin—bone cancer	0.000314	0.00193	CcSEcCtD
Trazodone—Malaise—Methotrexate—bone cancer	0.000312	0.00192	CcSEcCtD
Trazodone—Vertigo—Methotrexate—bone cancer	0.000311	0.00191	CcSEcCtD
Trazodone—Chills—Doxorubicin—bone cancer	0.000309	0.0019	CcSEcCtD
Trazodone—Arrhythmia—Doxorubicin—bone cancer	0.000308	0.00189	CcSEcCtD
Trazodone—Nausea—Cisplatin—bone cancer	0.000306	0.00188	CcSEcCtD
Trazodone—Vision blurred—Epirubicin—bone cancer	0.000306	0.00188	CcSEcCtD
Trazodone—Alopecia—Doxorubicin—bone cancer	0.000305	0.00187	CcSEcCtD
Trazodone—Ill-defined disorder—Epirubicin—bone cancer	0.000301	0.00185	CcSEcCtD
Trazodone—Anaemia—Epirubicin—bone cancer	0.0003	0.00184	CcSEcCtD
Trazodone—Agitation—Epirubicin—bone cancer	0.000298	0.00183	CcSEcCtD
Trazodone—Flatulence—Doxorubicin—bone cancer	0.000296	0.00182	CcSEcCtD
Trazodone—Arthralgia—Methotrexate—bone cancer	0.000295	0.00181	CcSEcCtD
Trazodone—Chest pain—Methotrexate—bone cancer	0.000295	0.00181	CcSEcCtD
Trazodone—Myalgia—Methotrexate—bone cancer	0.000295	0.00181	CcSEcCtD
Trazodone—Tension—Doxorubicin—bone cancer	0.000294	0.00181	CcSEcCtD
Trazodone—Dysgeusia—Doxorubicin—bone cancer	0.000294	0.00181	CcSEcCtD
Trazodone—Malaise—Epirubicin—bone cancer	0.000292	0.0018	CcSEcCtD
Trazodone—Discomfort—Methotrexate—bone cancer	0.000291	0.00179	CcSEcCtD
Trazodone—Nervousness—Doxorubicin—bone cancer	0.000291	0.00179	CcSEcCtD
Trazodone—Vertigo—Epirubicin—bone cancer	0.000291	0.00179	CcSEcCtD
Trazodone—Syncope—Epirubicin—bone cancer	0.000291	0.00179	CcSEcCtD
Trazodone—Back pain—Doxorubicin—bone cancer	0.00029	0.00178	CcSEcCtD
Trazodone—Palpitations—Epirubicin—bone cancer	0.000286	0.00176	CcSEcCtD
Trazodone—Confusional state—Methotrexate—bone cancer	0.000285	0.00175	CcSEcCtD
Trazodone—Loss of consciousness—Epirubicin—bone cancer	0.000285	0.00175	CcSEcCtD
Trazodone—Vision blurred—Doxorubicin—bone cancer	0.000283	0.00174	CcSEcCtD
Trazodone—Hypertension—Epirubicin—bone cancer	0.00028	0.00172	CcSEcCtD
Trazodone—Ill-defined disorder—Doxorubicin—bone cancer	0.000278	0.00171	CcSEcCtD
Trazodone—Anaemia—Doxorubicin—bone cancer	0.000277	0.0017	CcSEcCtD
Trazodone—Arthralgia—Epirubicin—bone cancer	0.000276	0.0017	CcSEcCtD
Trazodone—Myalgia—Epirubicin—bone cancer	0.000276	0.0017	CcSEcCtD
Trazodone—Chest pain—Epirubicin—bone cancer	0.000276	0.0017	CcSEcCtD
Trazodone—Agitation—Doxorubicin—bone cancer	0.000276	0.00169	CcSEcCtD
Trazodone—Anxiety—Epirubicin—bone cancer	0.000275	0.00169	CcSEcCtD
Trazodone—Hyperhidrosis—Methotrexate—bone cancer	0.000273	0.00168	CcSEcCtD
Trazodone—Discomfort—Epirubicin—bone cancer	0.000273	0.00168	CcSEcCtD
Trazodone—Malaise—Doxorubicin—bone cancer	0.000271	0.00166	CcSEcCtD
Trazodone—Dry mouth—Epirubicin—bone cancer	0.00027	0.00166	CcSEcCtD
Trazodone—Vertigo—Doxorubicin—bone cancer	0.00027	0.00166	CcSEcCtD
Trazodone—Anorexia—Methotrexate—bone cancer	0.00027	0.00166	CcSEcCtD
Trazodone—Syncope—Doxorubicin—bone cancer	0.000269	0.00165	CcSEcCtD
Trazodone—Confusional state—Epirubicin—bone cancer	0.000267	0.00164	CcSEcCtD
Trazodone—Palpitations—Doxorubicin—bone cancer	0.000265	0.00163	CcSEcCtD
Trazodone—Oedema—Epirubicin—bone cancer	0.000265	0.00163	CcSEcCtD
Trazodone—Hypotension—Methotrexate—bone cancer	0.000264	0.00162	CcSEcCtD
Trazodone—Loss of consciousness—Doxorubicin—bone cancer	0.000264	0.00162	CcSEcCtD
Trazodone—Shock—Epirubicin—bone cancer	0.00026	0.0016	CcSEcCtD
Trazodone—Hypertension—Doxorubicin—bone cancer	0.000259	0.00159	CcSEcCtD
Trazodone—Tachycardia—Epirubicin—bone cancer	0.000258	0.00159	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000258	0.00158	CcSEcCtD
Trazodone—Hyperhidrosis—Epirubicin—bone cancer	0.000256	0.00157	CcSEcCtD
Trazodone—Insomnia—Methotrexate—bone cancer	0.000256	0.00157	CcSEcCtD
Trazodone—Chest pain—Doxorubicin—bone cancer	0.000255	0.00157	CcSEcCtD
Trazodone—Myalgia—Doxorubicin—bone cancer	0.000255	0.00157	CcSEcCtD
Trazodone—Arthralgia—Doxorubicin—bone cancer	0.000255	0.00157	CcSEcCtD
Trazodone—Anxiety—Doxorubicin—bone cancer	0.000254	0.00156	CcSEcCtD
Trazodone—Paraesthesia—Methotrexate—bone cancer	0.000254	0.00156	CcSEcCtD
Trazodone—Discomfort—Doxorubicin—bone cancer	0.000252	0.00155	CcSEcCtD
Trazodone—Anorexia—Epirubicin—bone cancer	0.000252	0.00155	CcSEcCtD
Trazodone—Dyspnoea—Methotrexate—bone cancer	0.000252	0.00155	CcSEcCtD
Trazodone—Somnolence—Methotrexate—bone cancer	0.000251	0.00155	CcSEcCtD
Trazodone—Dry mouth—Doxorubicin—bone cancer	0.00025	0.00154	CcSEcCtD
Trazodone—Hypotension—Epirubicin—bone cancer	0.000247	0.00152	CcSEcCtD
Trazodone—Confusional state—Doxorubicin—bone cancer	0.000247	0.00152	CcSEcCtD
Trazodone—Decreased appetite—Methotrexate—bone cancer	0.000246	0.00151	CcSEcCtD
Trazodone—Oedema—Doxorubicin—bone cancer	0.000245	0.00151	CcSEcCtD
Trazodone—Fatigue—Methotrexate—bone cancer	0.000244	0.0015	CcSEcCtD
Trazodone—Pain—Methotrexate—bone cancer	0.000242	0.00149	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000241	0.00148	CcSEcCtD
Trazodone—Shock—Doxorubicin—bone cancer	0.000241	0.00148	CcSEcCtD
Trazodone—Insomnia—Epirubicin—bone cancer	0.000239	0.00147	CcSEcCtD
Trazodone—Tachycardia—Doxorubicin—bone cancer	0.000239	0.00147	CcSEcCtD
Trazodone—Paraesthesia—Epirubicin—bone cancer	0.000238	0.00146	CcSEcCtD
Trazodone—Hyperhidrosis—Doxorubicin—bone cancer	0.000237	0.00145	CcSEcCtD
Trazodone—Dyspnoea—Epirubicin—bone cancer	0.000236	0.00145	CcSEcCtD
Trazodone—Somnolence—Epirubicin—bone cancer	0.000235	0.00145	CcSEcCtD
Trazodone—Anorexia—Doxorubicin—bone cancer	0.000233	0.00143	CcSEcCtD
Trazodone—Feeling abnormal—Methotrexate—bone cancer	0.000233	0.00143	CcSEcCtD
Trazodone—Gastrointestinal pain—Methotrexate—bone cancer	0.000231	0.00142	CcSEcCtD
Trazodone—Decreased appetite—Epirubicin—bone cancer	0.00023	0.00141	CcSEcCtD
Trazodone—Hypotension—Doxorubicin—bone cancer	0.000229	0.00141	CcSEcCtD
Trazodone—Fatigue—Epirubicin—bone cancer	0.000228	0.0014	CcSEcCtD
Trazodone—Pain—Epirubicin—bone cancer	0.000226	0.00139	CcSEcCtD
Trazodone—Constipation—Epirubicin—bone cancer	0.000226	0.00139	CcSEcCtD
Trazodone—Urticaria—Methotrexate—bone cancer	0.000225	0.00138	CcSEcCtD
Trazodone—Abdominal pain—Methotrexate—bone cancer	0.000224	0.00137	CcSEcCtD
Trazodone—Body temperature increased—Methotrexate—bone cancer	0.000224	0.00137	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000223	0.00137	CcSEcCtD
Trazodone—Insomnia—Doxorubicin—bone cancer	0.000221	0.00136	CcSEcCtD
Trazodone—Paraesthesia—Doxorubicin—bone cancer	0.00022	0.00135	CcSEcCtD
Trazodone—Dyspnoea—Doxorubicin—bone cancer	0.000218	0.00134	CcSEcCtD
Trazodone—Feeling abnormal—Epirubicin—bone cancer	0.000218	0.00134	CcSEcCtD
Trazodone—Somnolence—Doxorubicin—bone cancer	0.000218	0.00134	CcSEcCtD
Trazodone—Gastrointestinal pain—Epirubicin—bone cancer	0.000216	0.00133	CcSEcCtD
Trazodone—Decreased appetite—Doxorubicin—bone cancer	0.000213	0.00131	CcSEcCtD
Trazodone—Fatigue—Doxorubicin—bone cancer	0.000211	0.0013	CcSEcCtD
Trazodone—Urticaria—Epirubicin—bone cancer	0.00021	0.00129	CcSEcCtD
Trazodone—Constipation—Doxorubicin—bone cancer	0.000209	0.00129	CcSEcCtD
Trazodone—Pain—Doxorubicin—bone cancer	0.000209	0.00129	CcSEcCtD
Trazodone—Abdominal pain—Epirubicin—bone cancer	0.000209	0.00129	CcSEcCtD
Trazodone—Body temperature increased—Epirubicin—bone cancer	0.000209	0.00129	CcSEcCtD
Trazodone—Hypersensitivity—Methotrexate—bone cancer	0.000208	0.00128	CcSEcCtD
Trazodone—Asthenia—Methotrexate—bone cancer	0.000203	0.00125	CcSEcCtD
Trazodone—Feeling abnormal—Doxorubicin—bone cancer	0.000202	0.00124	CcSEcCtD
Trazodone—Gastrointestinal pain—Doxorubicin—bone cancer	0.0002	0.00123	CcSEcCtD
Trazodone—Pruritus—Methotrexate—bone cancer	0.0002	0.00123	CcSEcCtD
Trazodone—Hypersensitivity—Epirubicin—bone cancer	0.000195	0.0012	CcSEcCtD
Trazodone—Urticaria—Doxorubicin—bone cancer	0.000194	0.0012	CcSEcCtD
Trazodone—Abdominal pain—Doxorubicin—bone cancer	0.000194	0.00119	CcSEcCtD
Trazodone—Body temperature increased—Doxorubicin—bone cancer	0.000194	0.00119	CcSEcCtD
Trazodone—Diarrhoea—Methotrexate—bone cancer	0.000193	0.00119	CcSEcCtD
Trazodone—Asthenia—Epirubicin—bone cancer	0.00019	0.00117	CcSEcCtD
Trazodone—Pruritus—Epirubicin—bone cancer	0.000187	0.00115	CcSEcCtD
Trazodone—Dizziness—Methotrexate—bone cancer	0.000187	0.00115	CcSEcCtD
Trazodone—Diarrhoea—Epirubicin—bone cancer	0.000181	0.00111	CcSEcCtD
Trazodone—Hypersensitivity—Doxorubicin—bone cancer	0.00018	0.00111	CcSEcCtD
Trazodone—Vomiting—Methotrexate—bone cancer	0.00018	0.00111	CcSEcCtD
Trazodone—Rash—Methotrexate—bone cancer	0.000178	0.0011	CcSEcCtD
Trazodone—Dermatitis—Methotrexate—bone cancer	0.000178	0.00109	CcSEcCtD
Trazodone—Headache—Methotrexate—bone cancer	0.000177	0.00109	CcSEcCtD
Trazodone—Asthenia—Doxorubicin—bone cancer	0.000176	0.00108	CcSEcCtD
Trazodone—Dizziness—Epirubicin—bone cancer	0.000175	0.00108	CcSEcCtD
Trazodone—Pruritus—Doxorubicin—bone cancer	0.000173	0.00106	CcSEcCtD
Trazodone—Vomiting—Epirubicin—bone cancer	0.000168	0.00103	CcSEcCtD
Trazodone—Nausea—Methotrexate—bone cancer	0.000168	0.00103	CcSEcCtD
Trazodone—Diarrhoea—Doxorubicin—bone cancer	0.000168	0.00103	CcSEcCtD
Trazodone—Rash—Epirubicin—bone cancer	0.000167	0.00103	CcSEcCtD
Trazodone—Dermatitis—Epirubicin—bone cancer	0.000167	0.00102	CcSEcCtD
Trazodone—Headache—Epirubicin—bone cancer	0.000166	0.00102	CcSEcCtD
Trazodone—Dizziness—Doxorubicin—bone cancer	0.000162	0.000995	CcSEcCtD
Trazodone—Nausea—Epirubicin—bone cancer	0.000157	0.000966	CcSEcCtD
Trazodone—Vomiting—Doxorubicin—bone cancer	0.000156	0.000957	CcSEcCtD
Trazodone—Rash—Doxorubicin—bone cancer	0.000154	0.000949	CcSEcCtD
Trazodone—Dermatitis—Doxorubicin—bone cancer	0.000154	0.000948	CcSEcCtD
Trazodone—Headache—Doxorubicin—bone cancer	0.000153	0.000943	CcSEcCtD
Trazodone—Nausea—Doxorubicin—bone cancer	0.000145	0.000894	CcSEcCtD
Trazodone—HRH1—GPCR downstream signaling—RGS1—bone cancer	6.18e-05	0.00157	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—GRM4—bone cancer	6.18e-05	0.00157	CbGpPWpGaD
Trazodone—ADRA2A—GPCR ligand binding—SMO—bone cancer	6.09e-05	0.00154	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—RGS1—bone cancer	6.07e-05	0.00154	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—GRM4—bone cancer	6.07e-05	0.00154	CbGpPWpGaD
Trazodone—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	6.03e-05	0.00153	CbGpPWpGaD
Trazodone—CYP2D6—Biological oxidations—GSTP1—bone cancer	5.97e-05	0.00151	CbGpPWpGaD
Trazodone—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	5.89e-05	0.00149	CbGpPWpGaD
Trazodone—HTR1A—SIDS Susceptibility Pathways—JUN—bone cancer	5.89e-05	0.00149	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—NDUFA12—bone cancer	5.88e-05	0.00149	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	5.7e-05	0.00144	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.68e-05	0.00144	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—GRM1—bone cancer	5.65e-05	0.00143	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—GRM4—bone cancer	5.64e-05	0.00143	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—RGS1—bone cancer	5.64e-05	0.00143	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—GRM4—bone cancer	5.63e-05	0.00143	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—RGS1—bone cancer	5.63e-05	0.00143	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—GRM1—bone cancer	5.62e-05	0.00142	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—GRM4—bone cancer	5.62e-05	0.00142	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—RGS1—bone cancer	5.62e-05	0.00142	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—RGS1—bone cancer	5.51e-05	0.0014	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—GRM4—bone cancer	5.51e-05	0.0014	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—SPARC—bone cancer	5.45e-05	0.00138	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—GRM1—bone cancer	5.37e-05	0.00136	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—GRM1—bone cancer	5.36e-05	0.00136	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—NT5C3A—bone cancer	5.32e-05	0.00135	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—GRM1—bone cancer	5.26e-05	0.00133	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—GRM4—bone cancer	5.12e-05	0.0013	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—RGS1—bone cancer	5.12e-05	0.0013	CbGpPWpGaD
Trazodone—HTR2A—SIDS Susceptibility Pathways—JUN—bone cancer	5.09e-05	0.00129	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—GNA11—bone cancer	4.98e-05	0.00126	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—GNA11—bone cancer	4.94e-05	0.00125	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—SMO—bone cancer	4.91e-05	0.00124	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.9e-05	0.00124	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—GRM1—bone cancer	4.89e-05	0.00124	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—GRM1—bone cancer	4.88e-05	0.00124	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—NT5C3A—bone cancer	4.88e-05	0.00124	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—GRM1—bone cancer	4.87e-05	0.00123	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—GRM1—bone cancer	4.78e-05	0.00121	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—RGS1—bone cancer	4.75e-05	0.0012	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—GRM4—bone cancer	4.75e-05	0.0012	CbGpPWpGaD
Trazodone—SLC6A4—Circadian rythm related genes—TP53—bone cancer	4.55e-05	0.00115	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—IL3—bone cancer	4.52e-05	0.00115	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—GNA11—bone cancer	4.49e-05	0.00114	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—IL3—bone cancer	4.48e-05	0.00114	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—NDUFA12—bone cancer	4.44e-05	0.00113	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—GRM1—bone cancer	4.44e-05	0.00112	CbGpPWpGaD
Trazodone—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	4.42e-05	0.00112	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	4.22e-05	0.00107	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—NDUFA12—bone cancer	4.18e-05	0.00106	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—GRM1—bone cancer	4.11e-05	0.00104	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—IL3—bone cancer	4.07e-05	0.00103	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—GNA11—bone cancer	4.01e-05	0.00102	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—GNA11—bone cancer	3.99e-05	0.00101	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—SMO—bone cancer	3.98e-05	0.00101	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—SMO—bone cancer	3.96e-05	0.001	CbGpPWpGaD
Trazodone—CYP3A4—Biological oxidations—GSTP1—bone cancer	3.9e-05	0.000989	CbGpPWpGaD
Trazodone—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.85e-05	0.000976	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—GRM4—bone cancer	3.85e-05	0.000975	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—RGS1—bone cancer	3.85e-05	0.000975	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—RGS1—bone cancer	3.83e-05	0.00097	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—GRM4—bone cancer	3.83e-05	0.00097	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—NT5C3A—bone cancer	3.68e-05	0.000932	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—GNA11—bone cancer	3.64e-05	0.000922	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—IL3—bone cancer	3.63e-05	0.000921	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—GNA11—bone cancer	3.62e-05	0.000917	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—IL3—bone cancer	3.61e-05	0.000916	CbGpPWpGaD
Trazodone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	3.56e-05	0.000903	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—NT5C3A—bone cancer	3.47e-05	0.000879	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—GNA11—bone cancer	3.46e-05	0.000877	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—GNA11—bone cancer	3.46e-05	0.000875	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—SMO—bone cancer	3.44e-05	0.000871	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—SMO—bone cancer	3.43e-05	0.000869	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—GNA11—bone cancer	3.39e-05	0.000859	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—SMO—bone cancer	3.37e-05	0.000853	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—GRM1—bone cancer	3.34e-05	0.000845	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—RGS1—bone cancer	3.32e-05	0.000842	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—GRM4—bone cancer	3.32e-05	0.000842	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—GRM1—bone cancer	3.32e-05	0.000841	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—GRM4—bone cancer	3.32e-05	0.000841	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—RGS1—bone cancer	3.32e-05	0.000841	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—IL3—bone cancer	3.3e-05	0.000836	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—IL3—bone cancer	3.28e-05	0.000832	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—RGS1—bone cancer	3.26e-05	0.000825	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—GRM4—bone cancer	3.26e-05	0.000825	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—GNA11—bone cancer	3.15e-05	0.000798	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—GNA11—bone cancer	3.14e-05	0.000797	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—IL3—bone cancer	3.14e-05	0.000795	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—GNA11—bone cancer	3.14e-05	0.000795	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—IL3—bone cancer	3.13e-05	0.000794	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.13e-05	0.000793	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—SMO—bone cancer	3.13e-05	0.000793	CbGpPWpGaD
Trazodone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	3.09e-05	0.000784	CbGpPWpGaD
Trazodone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	3.09e-05	0.000782	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—GNA11—bone cancer	3.08e-05	0.00078	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—IL3—bone cancer	3.07e-05	0.000779	CbGpPWpGaD
Trazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	3.03e-05	0.000768	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—GRM4—bone cancer	3.02e-05	0.000766	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—RGS1—bone cancer	3.02e-05	0.000766	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	3.02e-05	0.000765	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—PLAU—bone cancer	2.96e-05	0.000751	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—ENO2—bone cancer	2.95e-05	0.000749	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—SMO—bone cancer	2.9e-05	0.000735	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—GRM1—bone cancer	2.88e-05	0.00073	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—GRM1—bone cancer	2.88e-05	0.000729	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—GNA11—bone cancer	2.86e-05	0.000725	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—IL3—bone cancer	2.86e-05	0.000724	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL3—bone cancer	2.85e-05	0.000722	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL3—bone cancer	2.84e-05	0.000721	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—GRM1—bone cancer	2.82e-05	0.000715	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL3—bone cancer	2.79e-05	0.000707	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—DHFR—bone cancer	2.74e-05	0.000695	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—NDUFA12—bone cancer	2.74e-05	0.000693	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.72e-05	0.00069	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—GNA11—bone cancer	2.65e-05	0.000672	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—GRM1—bone cancer	2.62e-05	0.000664	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL3—bone cancer	2.59e-05	0.000657	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—GNA11—bone cancer	2.56e-05	0.000649	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—ATF1—bone cancer	2.46e-05	0.000625	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL3—bone cancer	2.4e-05	0.000609	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SMO—bone cancer	2.35e-05	0.000596	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SMO—bone cancer	2.34e-05	0.000593	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—ENO2—bone cancer	2.33e-05	0.000591	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—CYP3A4—bone cancer	2.32e-05	0.000589	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—NT5C3A—bone cancer	2.27e-05	0.000574	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—DHFR—bone cancer	2.16e-05	0.000548	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—GNA11—bone cancer	2.15e-05	0.000545	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.14e-05	0.000542	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—GNA11—bone cancer	2.14e-05	0.000542	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—ENO2—bone cancer	2.14e-05	0.000541	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TGFBR2—bone cancer	2.06e-05	0.000521	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SMO—bone cancer	2.03e-05	0.000515	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SMO—bone cancer	2.03e-05	0.000513	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—GNA11—bone cancer	2.02e-05	0.000512	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—ATF1—bone cancer	2e-05	0.000506	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SMO—bone cancer	1.99e-05	0.000504	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—ATF1—bone cancer	1.99e-05	0.000504	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—GSTP1—bone cancer	1.99e-05	0.000503	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—DHFR—bone cancer	1.98e-05	0.000502	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL3—bone cancer	1.95e-05	0.000494	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL3—bone cancer	1.94e-05	0.000491	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IGF1R—bone cancer	1.93e-05	0.00049	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—GNA11—bone cancer	1.86e-05	0.000471	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—GNA11—bone cancer	1.85e-05	0.00047	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—GNA11—bone cancer	1.85e-05	0.000469	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SMO—bone cancer	1.85e-05	0.000468	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—CYP3A4—bone cancer	1.83e-05	0.000464	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—GNA11—bone cancer	1.82e-05	0.000461	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.8e-05	0.000455	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ATF1—bone cancer	1.73e-05	0.000438	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ATF1—bone cancer	1.72e-05	0.000437	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ATF1—bone cancer	1.69e-05	0.000428	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—GNA11—bone cancer	1.69e-05	0.000428	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL3—bone cancer	1.68e-05	0.000427	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL3—bone cancer	1.68e-05	0.000426	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—CYP3A4—bone cancer	1.68e-05	0.000425	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TGFBR2—bone cancer	1.67e-05	0.000422	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TGFBR2—bone cancer	1.66e-05	0.00042	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL3—bone cancer	1.65e-05	0.000418	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—ENO2—bone cancer	1.61e-05	0.000408	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ATF1—bone cancer	1.57e-05	0.000398	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IGF1R—bone cancer	1.57e-05	0.000397	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—GSTP1—bone cancer	1.57e-05	0.000397	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IGF1R—bone cancer	1.56e-05	0.000395	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL3—bone cancer	1.53e-05	0.000388	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ENO2—bone cancer	1.52e-05	0.000385	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—DHFR—bone cancer	1.5e-05	0.000379	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TGFBR2—bone cancer	1.44e-05	0.000365	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TGFBR2—bone cancer	1.44e-05	0.000364	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—GSTP1—bone cancer	1.44e-05	0.000364	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	1.41e-05	0.000357	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—DHFR—bone cancer	1.41e-05	0.000357	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—KIT—bone cancer	1.4e-05	0.000355	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GNA11—bone cancer	1.4e-05	0.000354	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IGF1R—bone cancer	1.36e-05	0.000343	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IGF1R—bone cancer	1.35e-05	0.000343	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IGF1R—bone cancer	1.33e-05	0.000336	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—BRAF—bone cancer	1.32e-05	0.000334	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GNA11—bone cancer	1.32e-05	0.000334	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	1.31e-05	0.000332	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—EGFR—bone cancer	1.28e-05	0.000324	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CYP3A4—bone cancer	1.27e-05	0.000321	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IGF1R—bone cancer	1.23e-05	0.000312	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CYP3A4—bone cancer	1.19e-05	0.000303	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—TP53—bone cancer	1.19e-05	0.000302	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—KIT—bone cancer	1.14e-05	0.000288	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—KIT—bone cancer	1.13e-05	0.000287	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MDM2—bone cancer	1.1e-05	0.00028	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GSTP1—bone cancer	1.08e-05	0.000275	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—BRAF—bone cancer	1.07e-05	0.000271	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—BRAF—bone cancer	1.06e-05	0.00027	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.04e-05	0.000263	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—EGFR—bone cancer	1.03e-05	0.000261	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PTGS2—bone cancer	1.03e-05	0.000261	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GSTP1—bone cancer	1.02e-05	0.000259	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ENO2—bone cancer	9.93e-06	0.000252	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—KIT—bone cancer	9.83e-06	0.000249	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—KIT—bone cancer	9.81e-06	0.000248	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—KIT—bone cancer	9.62e-06	0.000244	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—JUN—bone cancer	9.6e-06	0.000243	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MMP9—bone cancer	9.34e-06	0.000237	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—BRAF—bone cancer	9.24e-06	0.000234	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—BRAF—bone cancer	9.22e-06	0.000234	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—DHFR—bone cancer	9.21e-06	0.000233	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—BRAF—bone cancer	9.05e-06	0.000229	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MDM2—bone cancer	8.96e-06	0.000227	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—EGFR—bone cancer	8.95e-06	0.000227	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—KIT—bone cancer	8.94e-06	0.000227	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—EGFR—bone cancer	8.93e-06	0.000226	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MDM2—bone cancer	8.91e-06	0.000226	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—EGFR—bone cancer	8.77e-06	0.000222	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GNA11—bone cancer	8.61e-06	0.000218	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—BRAF—bone cancer	8.4e-06	0.000213	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—EGFR—bone cancer	8.15e-06	0.000206	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PTGS2—bone cancer	8.12e-06	0.000206	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—JUN—bone cancer	7.79e-06	0.000197	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—JUN—bone cancer	7.75e-06	0.000196	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MDM2—bone cancer	7.74e-06	0.000196	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MDM2—bone cancer	7.72e-06	0.000196	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MDM2—bone cancer	7.58e-06	0.000192	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MMP9—bone cancer	7.58e-06	0.000192	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—EGFR—bone cancer	7.55e-06	0.000191	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MMP9—bone cancer	7.54e-06	0.000191	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PTGS2—bone cancer	7.44e-06	0.000189	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MDM2—bone cancer	7.04e-06	0.000178	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—JUN—bone cancer	6.73e-06	0.00017	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—JUN—bone cancer	6.71e-06	0.00017	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GSTP1—bone cancer	6.68e-06	0.000169	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—JUN—bone cancer	6.59e-06	0.000167	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MMP9—bone cancer	6.55e-06	0.000166	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MMP9—bone cancer	6.53e-06	0.000165	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MMP9—bone cancer	6.41e-06	0.000162	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TP53—bone cancer	6.34e-06	0.000161	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—EGFR—bone cancer	6.12e-06	0.000155	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—JUN—bone cancer	6.12e-06	0.000155	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—EGFR—bone cancer	6.09e-06	0.000154	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MMP9—bone cancer	5.95e-06	0.000151	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PTGS2—bone cancer	5.61e-06	0.000142	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PTGS2—bone cancer	5.29e-06	0.000134	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—EGFR—bone cancer	5.29e-06	0.000134	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—EGFR—bone cancer	5.28e-06	0.000134	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—EGFR—bone cancer	5.18e-06	0.000131	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TP53—bone cancer	5.14e-06	0.00013	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TP53—bone cancer	5.11e-06	0.00013	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—EGFR—bone cancer	4.81e-06	0.000122	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TP53—bone cancer	4.44e-06	0.000113	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TP53—bone cancer	4.43e-06	0.000112	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TP53—bone cancer	4.35e-06	0.00011	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TP53—bone cancer	4.04e-06	0.000102	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTGS2—bone cancer	3.46e-06	8.76e-05	CbGpPWpGaD
